Top drug makers such as Sun Pharmaceutical Industries, Dr Reddy’s Laboratories and Cadila Healthcare faced US import ban on their key production facilities in India
Read More“The dental adhesives market in Asia Pacific will witness significant growth during the forecast period due to the low cost of procedures and growth in medical tourism.”
Read MoreWith price control over cardiac stents and generic prescription proposal, medical device makers and pharmaceutical giants are expected to hand over pink slips to their employees
Read MoreSpeaking at an event of Rashtriya Ayurveda Vidyapeeth, Ansari said, "Ayurvedic medicine still remains an important component of our healthcare system. It is a traditional healing system of India, going back at least to the Vedic times."
Read MoreDrug makers blame price controls over the short supply of the drug. Mankind Pharmaceuticals stopped manufacturing the drug as soon as the price control was announced. The company says they paid taxes out of their own pocket due to nonviable costing
Read MoreEven after four decades prior to the introduction of sanitary napkins, the soaring prices, high level of tax and the hushed voices of women at the doorstep of medical stores, collectively paint the landscape of sanitation industry.
Read MoreIndia has to go through a procedural adaptation of technology and there is no way out, because of the super complex structure of Healthcare in India, he concluded.
Read MoreThe government announced several good reforms, but without a roadmap or a time frame, they made little difference
Read More